IMS Health prices initial public offering
The healthcare data firm is putting 52m shares up for sale, with the resulting proceeds – around $1bn – earmarked for paying down existing long-term debt.
Meanwhile, the investment firms that took IMS private in a $5bn deal in 2010 will sell 13m shares – returning $260m to their coffers.
IMS filed for an IPO in January this year. The offering is expected to close on 9 April. Shares are expected to begin trading on the New York Stock Exchange (NYSE) today under the ticker symbol IMS.
Pictured is IMS CEO Ari Bousbib.
UPDATE: IMS shares opened at $22.18 on the NYSE this morning. As of 10.15am ET they were trading at $22.85.

We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments